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Background: Care homes are experiencing large outbreaks of COVID-19 associated with high case-fatality
rates. We conducted detailed investigations in six London care homes reporting suspected COVID-19 out-
breaks during April 2020.
Methods: Residents and staff had nasal swabs for SARS CoV-2 testing using RT-PCR and were followed-up for
14 days. They were categorized as symptomatic, post-symptomatic or pre-symptomatic if they had symp-
toms at the time of testing, in the two weeks before or two weeks after testing, respectively, or asymptomatic
throughout. Virus isolation and whole genome sequencing (WGS) was also performed.
Findings: Across the six care homes, 105/264 (39.8%) residents were SARS CoV-2 positive, including 28
(26.7%) symptomatic, 10 (9.5%) post-symptomatic, 21 (20.0%) pre-symptomatic and 46 (43.8%) who
remained asymptomatic. Case-fatality at 14-day follow-up was highest among symptomatic SARS-CoV-2
positive residents (10/28, 35.7%) compared to asymptomatic (2/46, 4.3%), post-symptomatic (2/10, 20.0%) or
pre-symptomatic (3/21,14.3%) residents. Among staff, 53/254 (20.9%) were SARS-CoV-2 positive and 26/53
(49.1%) remained asymptomatic. RT-PCR cycle-thresholds and live-virus recovery were similar between
symptomatic/asymptomatic residents/staff. Higher RT-PCR cycle threshold values (lower virus load) samples
were associated with exponentially decreasing ability to recover infectious virus (P<0.001). WGS identified
multiple (up to 9) separate introductions of different SARS-CoV-2 strains into individual care homes.
Interpretation: A high prevalence of SARS-CoV-2 positivity was found in care homes residents and staff, half
of whom were asymptomatic and potential reservoirs for on-going transmission. A third of symptomatic
SARS-CoV-2 residents died within 14 days. Symptom-based screening alone is not sufficient for outbreak
control.
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Amid the COVID-19 pandemic, community care facilities includ-
ing nursing and residential homes have been termed “hubs” and
“besieged castles” in North America and Europe, having experienced
Research in context
Evidence before this study
We searched PubMed with the terms “COVID-19 outbreak” or
“SARS-CoV-2 outbreak” and “care home”, “nursing home”,
“nursing facility” or “residential home” to identify publications
relating to COVID-19 outbreaks since January 2020, focusing
particularly on those where enhanced outbreak investigations
were undertaken.
Large COVID-19 outbreaks associated with high cases fatal-
ity rates among residents have been reported worldwide. Out-
break investigation of single care homes identified high rates of
asymptomatic and pre-symptomatic SARS-CoV-2detection by
the time an outbreak is identified. Live virus has been isolated
from asymptomatic residents and staff highlighting their
potential for transmission within the care home setting. Whole
genome sequence analysis identified the outbreak strains to be
indistinguishable to those circulating in the local community.
Added value of this study
We found very high rates of SARS-CoV-2 positivity among resi-
dents (40%, range 2679%) and staff (20%) in London care
homes experiencing a COVID-19 outbreak, most of whom were
asymptomatic at the time of testing. Case fatality at 14 days
was high among symptomatic RT-PCR positive residents (36%)
compared to asymptomatic SARS-COV-2 positive residents
(4%). Individual genomic clusters involved multiple residents
and at least one positive staff member within the same care
home.
Implications of all the available evidence
Asymptomatic SARS-CoV-2 positive residents and staff are
likely to be acting as potential reservoirs for local infection and
transmission within care homes. Further studies are needed to
assess whether infected residents and staff develop protective
antibodies against SARS-CoV-2.
Fig. 1. SARS-CoV-2 positivity, symptoms, live virus isolation and deaths in residents and staf
SARS-CoV-2 positive residents, live virus was isolated from 5/17 (29.4%) of symptomatic an
(35.0%) survivors compared with 5/10 (50.0%) of fatal cases (P = 0.38).
2 S.N. Ladhani et al. / EClinicalMedicine 26 (2020) 100533large outbreaks due to rapid transmission of SARS-CoV-2 [13]. Care
homes have a unique, mixed population of multi-disciplinary staff
and frail residents with multiple underlying comorbidities [4, 5].
Such residents are at high risk of severe complications and death due
to respiratory viruses, such as influenza [6], and now COVID-19
[710].
In the UK, the first imported COVID-19 cases were confirmed in
late January 2020 and autochthonous transmission confirmed in late
February 2020. Case numbers increased rapidly from early March,
with nationwide lockdown being announced on 23 March. London
experienced faster transmission and higher rates of COVID-19 cases
than any other region in the UK [11], with many care homes report-
ing large and sustained outbreaks, associated with high case-fatality
rates (CFR) [8]. In England and Wales, there were 45,899 deaths
among care home residents between March 02 and May 02 and
12,526 (27.3%) involved COVID-19 [12].
Beginning April 10, Public Health England (PHE) undertook an
enhanced outbreak investigation in six London care homes
experiencing COVID-19 outbreaks to increase understanding of dis-
ease transmission and inform urgent public health interventions. We
assessed SARS-CoV-2 positivity in residents and staff at the care
homes and followed them daily for two weeks. We evaluated differ-
ences in outcomes according to SARS-CoV-2 positivity, viral load and
recovery of infectious virus according to timing and presence or
absence of symptoms. We used whole genome sequence (WGS) anal-
yses to inform about likely transmission routes infection.
Methods
We identified six care homes reporting a suspected outbreak (2
suspected cases) of COVID-19 to PHE during 1013 April 2020. These
were mainly nursing or mixed nursing/residential homes of different
sizes, providing care for 43100 residents with 14130 staff. The
care homes were in different stages of a COVID-19 outbreak. The ear-
liest care home outbreak began on March 11 (CH1) and they had
experienced 29 fatalities by the time of swabbing while the last
home’s outbreak began on April 07 with two fatalities among resi-
dents (Supplement Fig. 1). Initial contact with the care home involved
conducting a risk assessment and immediate infection preventionf across six London care homes experiencing a COVID-19 outbreak during April 2020. In
d 14/33 (42.4%) of asymptomatic residents at the time of testing (P = 0.37) and 14/40
S.N. Ladhani et al. / EClinicalMedicine 26 (2020) 100533 3and control advice was provided as per standard UK guidance. (Sup-
plement Table 1).
We assessed SARS-CoV-2 positivity in the residents and staff
(carers and those without caring duties), recorded their symptoms in
the two weeks prior to sampling and followed them daily for new
symptoms and outcomes for two weeks through daily phone-call and
datasheet completion. Care home data were collected systematically
covering resident demographics, facilities, staffing and infection con-
trol measures in place at the time of swabbing (Supplement Table
2). Staff working at the care home during the days of testing took
nasal swabs for the residents and submitted their own samples by
self-swabbing with appropriate instructions. Symptom status at the
time of testing (symptomatic or asymptomatic) was recorded on the
sample submission form.
Laboratory methods
Swabs from all six homes were couriered to the PHE reference
laboratory on the day they were collected. Nucleic acid was extracted
and analysed by a real-time reverse transcription (RT) PCR assay on
an Applied Biosystems 7500 FAST system targeting a conserved
region of the open reading frame (ORF1ab) gene of SARS-CoV-2,
together with an internal control [13]. With RT-PCR, a positive reac-
tion is detected by accumulation of a fluorescent signal. The cycle
threshold (Ct) is defined as the number of amplification cycles
required for the fluorescent signal to cross a pre-defined threshold
(i.e. exceeds background level). Ct levels are inversely proportional to
the amount of target nucleic acid in the sample so that lower Ct val-
ues reflect greater amount of target nucleic acid in the sample and
hence higher viral loads. Detection of virus by RT PCR may not reflect
the amount of infectious virus present. All SARS-CoV-2 positive sam-
ples with a Ct value of <35 were incubated on Vero E6 mammalian
cells and virus detection was confirmed by cytopathic effect (CPE) up
to 14 days post-inoculation. Whole genome sequencing (WGS) was
performed on all RT-PCR positive samples [14]. Viral amplicons were
sequenced using Illumina library preparation kits (Nextera) and
sequenced on Illumina short-read sequencing machines. Raw
sequence data was trimmed and aligned against a SARS-CoV-2 refer-
ence genome (NC_045512.2). A consensus sequence representing
each genome base was derived from the reference alignment. Con-
sensus sequences were assessed for quality, aligned using MAFFT
(Multiple Alignment using Fast Fourier Transform, version 7.310),
manually curated and maximum likelihood phylogenetic trees
derived using IQtree (version 2.04).
Case definitions
A symptomatic individual was defined as typical COVID-19 symp-
toms (fever, persistent cough, sore throat, or shortness of breath; at
that time, anosmia was not part of the case definition) in a staff mem-
ber or resident and included additionally atypical (new confusion,
reduced alertness, fatigue, lethargy, reduced mobility, diarrhea)
COVID-19 symptoms in a resident at the time of swabbing. Post-
symptomatic individuals had symptoms during the 14 days prior but
were asymptomatic at the time of swabbing. Pre-symptomatic indi-
viduals developed symptoms in the 14 days after swabbing. Asymp-
tomatic individuals did not exhibit any symptoms during the two
weeks before or after swabbing.
Statistical analysis
Data are mainly descriptive. Data that did not follow a normal dis-
tribution were described as medians with interquartile ranges and
compared using the Mann-Whitney U test. Categorical variables
were described as proportions and compared using the chi-squared
or Fisher’s Exact test as appropriate. Logistic regression was used toassess independent risk factors for death among residents and
included age in years, gender and RT-PCR positivity by symptom sta-
tus at the time of swabbing.
Ethical approval
PHE has legal permission, provided by Regulation 3 of The Health
Service (Control of Patient Information) Regulations 2002, to process
patient confidential information for national surveillance of commu-
nicable diseases and as such, individual patient consent is not
required.
Role of the funding source: This study did not receive any funding.
The authors had sole responsibility for the study design, data collec-
tion, data analysis, data interpretation, and writing of the report. The
authors are all employed by Public Health England, the study funder,
which is a public body — an executive agency of the Department of
Health. The first and last authors had full access to all the data in the




The 518 individuals tested during the enhanced care home inves-
tigation included 264 residents and 254 staff members. Of the 264
residents, 105 (39.8%) were SARS-CoV-2 positive. Four residents
were hospitalised and 21 (8.0%) died, including two of the hospital-
ised cases, within two weeks of testing. Their characteristics, symp-
tom status and clinical outcomes are summarised in Table 1. Of the
105 SARS-CoV-2 positive residents, only 28 (26.7%) were symptom-
atic at the time of testing. Additional follow-up identified 10/105
(9.5%) residents as post-symptomatic, 21 (20.0%) pre-symptomatic
and 46 (43.8%) who remained asymptomatic throughout the surveil-
lance period (Fig. 1). The positive predictive value for SARS-CoV-2 in
a resident who is symptomatic at the time of testing was 53.8% (28/
52) and being symptomatic at any time within the follow-up period
was 62.1% (59/95). The negative predictive value of being SARS-CoV-
2 negative if asymptomatic at the time of testing was 63.7% (135/
212), and being asymptomatic throughout the surveillance period
was 77.4% (123/159). Of the 67 SARS-COV-2 positive residents who
were asymptomatic before or at the time of testing, 21 (31.3%) devel-
oped symptoms in the following two weeks. Among the 159 resi-
dents who tested negative, 24 (15.1%) were symptomatic at testing, 4
(2.5%) reported symptoms consistent with COVID-19 in the previous
two weeks and 8 (5.0%) developed symptoms after the test but were
not re-tested for SARS-CoV2 (Table 2). There was no difference in age
or sex between symptomatic and asymptomatic residents overall or
by SARS-CoV-2 positivity status.
14-day case fatality rate
CFR within 14 days of testing was significantly higher in residents
who were symptomatic at the time of testing compared with those
who were asymptomatic, regardless of SARS-CoV-2 result (11/52
[21.2%] vs. 10/212 (4.7%); P<0.001) (Table 2, Fig. 1). Ten of the 28
(35.7%) SARS-CoV-2 positive residents who were symptomatic at the
time of testing died within 14 days compared to 1/24 (4.2%) of symp-
tomatic residents who tested negative (P = 0.005). Of the 212 resi-
dents who were asymptomatic at the time of testing, 77 (36.3%)
tested positive for SARS-CoV-2 and the 14-day CFR was 9.1% (7/77)
compared to a 14-day CFR of 2.2% (3/135) in those who tested SARS-
CoV-2 negative (P = 0.023).
Among SARS-CoV-2 positive residents, 10/28 (35.7%) symptom-
atic residents died within 14 days compared to only 2/46 (4.3%)





































































































































































































































































































































































































































































































































































































































4 S.N. Ladhani et al. / EClinicalMedicine 26 (2020) 100533(14.3%) pre-symptomatic residents (P = 0.005). Among SARS-CoV-2
negative residents, 4/159 (2.5%) (3 asymptomatic, 1 symptomatic)
died (Fig. 1). After adjusting for age in years (aOR 1.0; 95%CI,
0.971.1; P = 0.49) and being female (aOR 1.7; 95%CI, 0.446.5;
P = 0.45). in a multivariable logistic regression model, residents who
were RT-PCR positive and symptomatic at the time of testing (aOR
21.8; 95% CI, 5.487.5; P<0.0001) and those who were RT-PCR posi-
tive but asymptomatic at the time of testing (aOR 4.3; 95% CI,
1.117.0; P = 0.04) but not residents who were symptomatic and
SARS-CoV-2 RT-PCR negative (aOR 1.8; 95% CI, 0.1818.5; P = 0.61)
had a significantly higher odds of death within 14 days of testing
compared to asymptomatic and SARS-CoV-2 RT-PCR negative.
Care home staff
In total, 254/474 (53.6%) staff were tested and 53 (20.9%) were
SARS-CoV-2 positive but only 12 were symptomatic at the time of
swabbing (Fig. 1). The positive predictive value of a symptomatic staff
member being positive for SARS-CoV-2 was 38.7% (12/31) and the
negative predictive value of being asymptomatic at the time of test-
ing and negative for SARS-CoV-2 was 81.6% (182/223). Follow-up of
the 53 SARS-CoV-2 positive staff members found 26 (49.1%) did not
develop any symptoms in the two weeks before or after testing,
whereas four (7.5%) were pre-symptomatic and 11 (20.8%) were
post-symptomatic. Thus, of the 30 staff who had no historical or con-
temporaneous symptoms at the time of swabbing, only 4 (13.3%)
went on to develop symptoms in the subsequent two weeks. There
was no difference in age or sex between symptomatic and asymp-
tomatic staff overall or by SARS-CoV-2 positivity status. All staff
members survived their infection.
Cycle threshold and viral culture
There was no difference in Ct values for SARS-CoV-2 positive resi-
dents or staff who were post-symptomatic, symptomatic or pre-
symptomatic at the time of swabbing compared to asymptomatic res-
idents (Fig. 2a). In total, 87 samples with Ct values <35 were cultured
and infectious virus was recovered from all of categories of symptom-
atic, post-symptomatic, pre-symptomatic and asymptomatic resi-
dents and staff. Based on symptom reporting alone (without repeat
SARS-CoV-2 testing), live virus was isolated up to 13 days after and
12 days before symptom onset among residents and up to 6 days
before and 7 days after symptom onset among staff (Supplement
Table 3). Higher Ct values (lower virus load) samples are associated
with decreasing ability to recover infectious virus from 100% (2/2)
with Ct <20.00 to 17.0% (9/53) with Ct 30.0034.99 (x2 for trend,
P<0.001) (Fig. 2b), but showed no correlation with presence or
absence of symptoms in staff or residents (Supplement Table 4). Virus
recovery rates were similar in symptomatic and asymptomatic resi-
dents (5/17 [29.4%] vs. 14/33 [42.4%]; P = 0.37) and staff (2/6 [33.3%]
vs. 10/31 [32.3%]; P = 0.96) at the time of testing, and were not differ-
ent between fatal and non-fatal cases among residents (5/10 [50.0%]
vs. 14/40 [35.0%]; P = 0.38).
WGS analysis
All 158 PCR positive samples underwent WGS analysis and 99 (68
residents, 31 staff) distributed across all the care homes yielded
sequence sufficient for WGS analysis (Supplement Table 5). Phyloge-
netic analysis identified informal clusters, with evidence for multiple
introductions of the virus into care home settings. All care home clus-
ters of SARS-CoV-2 genomes included at least one staff member,
apart from care home B with no PCR positive staff and high rates of
staff self-isolation. Care home A exhibited three distinct sequence
clusters and six singletons, potentially representing up to nine sepa-
rate introductions. Genomic analysis did not identify any differences
Table 2
Characteristics of residents and staff in all six care homes.
Symptom status
Asymptomatic Post-symptomatic Pre-symptomatic Symptomatic All
RESIDENTS
SARS-CoV-2 Positive N = 46 N = 10 N = 21 N = 28 N = 105
Female (%) 30 (65.2%) 10 (100%) 17 (81.0%) 25 (89.3%) 82 (78.1%)
Median age in years (IQR) 84 (7890) 88 (8591) 84 (8091) 87 (8091) 85 (7890)
Median days symptom onset (IQR) x 5 (6 to 3) 4 (2 to 11) 7 (10 to 4)
Hospitalised x x 1 (4.8%) 2 (7.1%)
Died 2 (4.4%) 2 (20.0%) 3 (14.3%) 10 (35.7%) 17 (16.2%)
SARS-COV-2 Negative n = 123 n = 4 n = 8 n = 24 n = 159
Female (%) 84 (68.3%) 1 (25.0%) 6 (75.0%) 18 (75.0% 109 (68.6%)
Median age in years (IQR) 85 (7890) 81 (7487) 84 (8088) 86 (8089) 85 (8091)
Median days symptom onset (IQR) x 7 (8 to 5) 13 (1213) 8 (13 to 6)
Hospitalised x x 1 (12.5%) x
Died 3 (2.4%) x x 1 (4.2%) 4 (2.5%)
STAFF
SARS-CoV-2 Positive N = 26 N = 11 N = 4 N = 12 N = 53
Female (%) 16 (61.5%) 7 (63.6%) 3 (75.0%) 8 (66.7%) 34 (64.2%)
Median age in years (IQR) 50 (4056) 54 (4159) 38 (3449) 40 (2655) 47 (3857)
Median symptom onset (IQR) x 7 (9 to 4) 3 (25) 5 (9 to 3)
SARS-CoV-2 Negative N = 176 N = 4 N = 2 N = 19 N = 201
Female (%) 147 (83.5%) 2 (50.0%) 2 (100%) 16 (84.2%) 167 (83.1%)
Median age in years (IQR) 47 (3956) 52 (2677) 50 (3565) 43 (2957) 47 (3556)
Median symptom onset (IQR) x N/A 9 days * 6 (16 to 5)
* onset date not available for one resident; N/A, not available for two staff members.
S.N. Ladhani et al. / EClinicalMedicine 26 (2020) 100533 5between asymptomatic/symptomatic residents/staff. The ten sequen-
ces from residents who died were distributed across the lineages
identified and were closely matched to sequences derived from non-
fatal cases in the same care homes (Fig. 3).
Discussion
Investigation of six London care homes experiencing SARS Cov-2
outbreaks identified a high proportion of residents (39.8%) and staff
(20.9%) who tested positive for SARS-CoV-2, of whom three-quarters
were asymptomatic at the time of testing and half remained asymp-
tomatic throughout the surveillance period, highlighting the silent
nature of infection in this setting. The homes were at different stages
of a SARS-CoV-2 outbreak with some already having experienced a
high number of deaths. Among residents, SARS-CoV-2 positivity and
being symptomatic were strong predictors of death. The large num-
bers of deaths that had already occurred prior to our investigations
highlights the potential for prolonged COVID-19 outbreaks in institu-
tional settings. RT-PCR Ct values and recovery of live viruses were
similar among asymptomatic and symptomatic residents and staff
despite the large age difference between the groups and also did not
appear to alter the ratio between symptomatic and asymptomatic
infections. We identified multiple introductions of the virus into indi-
vidual care homes and individual care home clusters included at least
one staff member. Genomic analysis did not identify any differences
between asymptomatic/symptomatic residents/staff or between fatal
and non-fatal cases.
Our findings provide further evidence for pre-symptomatic infec-
tion among residents in care homes experiencing a COVID-19 out-
break [10, 15, 16], but also identified a large cohort of residents and
staff who remained asymptomatic throughout the surveillance
period. A recent detailed longitudinal investigation of a COVID-19
outbreak in a single nursing facility in Seattle, Washington state,
highlighted important common features and some key differences
compared to our cohort [10]. The high rate of asymptomatic residents
at the time of first (23/76, 30%) and second (24/49, 49%) swabbing a
week later in the Seattle investigation is consistent with our findings
of a high but variable prevalence of asymptomatic SARS-CoV-2 posi-
tive residents in care homes at different stages of a COVID-19
outbreak. The high 14-day case-fatality rate of 35.7% amongsymptomatic SARS-CoV-2 positive residents in our cohort was also
consistent with the 26% reported in the Seattle care home.
However, while >85% of asymptomatic residents in the Seattle
investigation went on to develop symptoms over the next seven days
[10], in our cohort, half the residents remained asymptomatic during
the surveillance period, possibly because of the maturity of the out-
breaks in the London care homes at the time of testing, as evidenced
by the number of deaths that had already occurred, although mild/
non-specific symptoms might not have been identified by the care
staff [17].
We did not observe any correlation in the RT-PCR CT values
between symptomatic and asymptomatic residents or staff, nor any
association with age, indicating that symptomatic and asymptomatic
residents and staff of all ages had similar viral loads when infected
with SARS-CoV-2. Like the Seattle investigation [10], and others [16,
18], we also found high rates of live virus isolation among symptomatic
and asymptomatic residents and staff, highlighting the enormous
potential for silent transmission of infection and the futility of symp-
tom-based only surveillance in care homes and other similar settings
[6]. We found that 20.0% of asymptomatic residents went on to develop
symptoms at a median of four days after testing but, in our longer fol-
low-up, some residents developed symptoms consistent with COVID-
19 up to 13 days later, although repeat testing was not performed to
confirm the diagnosis. Together with the Seattle investigation where
live virus was isolated from specimens taken up to 6 days before and
9 days after the first symptoms [10], these findings provided the evi-
dence for current recommendations to isolate test-positive residents
for at least 14 days and test-positive staff for 7 days, although the latter
has now been extended to 10 days in England.
Some SARS-COV-2-negative residents and staff in our cohort
became symptomatic in the second week after testing which may
indicate on-going transmission, but we did not undertake additional
testing to confirm this. More regular screening with systematic test-
ing of all residents and staff, irrespective of symptoms, and longer fol-
low-up may have provided additional information on SARS-CoV-2
transmission and outcomes.
Genomic analysis of SARS-COV-2 strains identified separate intro-
ductions with distinct clusters that included at least one member of
staff within each cluster, raising the question as to whether staff
members might be the source of the infection, although it was not
Fig. 2. a. Boxplot showing median Cycle Threshold (Ct) values with interquartile ranges
(Boxes) along with minimum (Q11.5*IQR) and maximum (Q3+1.5*IQR) values (whiskers)
and outlier values (blue circles) for asymptomatic, post-symptomatic, pre-symptomatic and
symptomatic residents and staff. 2b. Live virus isolation by RT-PCR Cycle threshold (t) range
in residents and staff of care homes. The data points include live virus isolation by number
of strains tested.
Table 3
Potential strategies for prevention of COVID-19 in care home.
 Prevention is fundamental to controlling outbreaks in care homes by reduc-
ing introduction of SARS-CoV2, increasing infection prevention control
(IPC) and early detection of COVID-19 cases in Care homes.
 Ensure early testing of unwell residents including those with atypical
COVID-19 symptoms (drowsiness, reduced appetite, lethargy and fatigue)
 Limit close contact between residents along with immediate isolation of
residents as soon as a single case is suspected
 Ensure residents are isolated for 14 days after a known high-risk exposure
(e.g. admission to hospital), consider intermediate care and other local sup-
port to minimize risk of introduction into the home.
 Test Staff (any staff, not just carers) who are unwell with any symptoms,
typical or atypical and ensure that they are negative for SARS-CoV-2 and
asymptomatic (other viruses can cause similar illnesses) before they enter
care home
 Exclude SARS-CoV-2 positive staff for 7 days from work, irrespective of
whether symptomatic or asymptomatic at the time of testing (current
guidelines in England now recommend 10 days exclusion)
 Avoid where possible, agency staff and ensure they get appropriate IPC
training before they enter the care home
 Wider testing in the care home during the early detection of an outbreak:
test all (including staff) those in contact with unwell resident including staff
 this may be one part or one floor or the whole care home (residents and
staff). The same principle applies for testing staff and residents who have
been in contact with symptomatic staff
 Enhanced cleaning of high touch surfaces and hand hygiene before and after
every resident contact
 Rigorous and systematic testing policy for staff and residents, with particu-
lar attention to infection control measures for visitors, new residents and
movement of residents and staff from other facilities.
6 S.N. Ladhani et al. / EClinicalMedicine 26 (2020) 100533possible to confirm the direction of infection with a single snapshot
survey. In addition to staff, other potential sources included residents
returning to care homes from hospitals at a time when they were not
routinely tested for SARS-CoV-2 prior to discharge, new residents
being admitted from the community or from other care homes, and
visitors to the care homes [19].
The strengths of this investigation lie in the large number of resi-
dents and staff tested through a single national reference center across
six different care homes each at different stages of a COVID-19 out-
break, with detailed virological analyses. Extensive and complete daily
follow-up provided detailed understanding of symptom progression
and identified a high prevalence of asymptomatic SARS-CoV-2 residents
and staff who may serve as potential reservoirs of infection. This was
the first systematic public health investigation of care home outbreaks
in England and the findings, which were reported to decision makers
in real time, played an important part in supporting national policy and
support for care homes [20]. The six care homes were mainly nursing
homes that were selected for enhanced investigations because they
were experiencing large outbreaks within the same locality; they were
not intended to be representative of the wider care home settings
nationally. We collected minimal data on a large number of residentsand staff to ensure complete ascertainment of symptoms and outcomes
in order to understand infection and transmission of SARS-CoV-2 in
care homes. We, therefore, did not collect detailed information on eth-
nicity, comorbidity or frailty status of the residents, which are also
important determinants of outcomes [2123]. We also did not use
standard questionnaires to collect symptoms, allowing instead the staff
to assess the residents who they knew well and report symptoms in
free text. A limitation of the investigation was that we only tested the
care homes once. Additional testing would have allowed more objec-
tive tracking of transmission and diagnosis in pre-symptomatic resi-
dents and staff, while testing for other viruses may have explained the
development of new symptoms in SARS/CoV-2 positive and negative
residents and staff. Moreover, SARS-CoV-2 testing detection could have
been improved by testing multiple sites, such as the nose and throat
[24], and repeated testing, but this was impractical in our cohort. We
also only tested staff who were working at the care home at the time
of the investigation and, therefore, may have missed testing those who
were symptomatic and self-isolating at home.
Our results highlight the difficulties in controlling SARS-CoV-2
outbreaks in care homes and other institutional settings despite
extensive infection control guidance and training [25, 26]. Infectious
virus recovery in asymptomatic staff and residents emphasises their
likely importance as silent reservoirs and transmitters of infection
and explains the failure of infection control measures which have
been largely based on identification of symptomatic individuals.
When transmission is occurring in the community, enhanced infec-
tion prevention and control measures should be quickly imple-
mented in care homes, along with rigorous and systematic testing for
SARS-Cov-2 among staff and residents, with particular attention to
infection control measures for visitors, new residents and movement
of residents and staff from other facilities. Early and wide testing of
residents and staff, along with immediate isolation of suspected
cases, may help control the introduction and spread of SARsCoV-2
into care homes (Table 3). Point-of-care testing for SARS-
CoV2 antigens/antibodies, if sufficiently sensitive and accurate, could
potentially have a role in the near future.
Fig. 3. Maximum Likelihood phylogeny of 99 SARS-CoV-2 genomes from individuals within six care homes. Coloured branches are used to indicate the care home, staff are anno-
tated on the tree with (S), genomes from patients who died after testing positive for covid-19 are shown with (X). Unannotated tips in the phylogeny represent genomes from care
home residents.
S.N. Ladhani et al. / EClinicalMedicine 26 (2020) 100533 7Care home residents are very vulnerable to COVID-19 and have a
high case-fatality rate, particularly if symptomatic at the time of
swabbing. With sustained community transmission, testing of all res-
idents and staff irrespective of symptoms combined with measures
to prevent virus introduction into care homes and robust infection
prevention and control measures will be needed to control SARS-
CoV-2 outbreaks in care homes. Further investigations to better
understand transmission dynamics in care home, especially in rela-
tion to asymptomatic infection among residents and staff, are needed
to develop a more tailored approach to SARS-CoV-2 outbreak control.
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